Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Hovenga · SciRah

Researcher profile · Semantic Scholar

S. Hovenga

Share profile

S. Hovenga — researcher profile on SciRah

h-index: 14
Works: 28
Citations: 1,106

Most-cited papers

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
A. Cats, E. Jansen, N. V. van Grieken, K. Sikorska +92 more
2018The Lancet Oncology470 citations
Semantic Scholar
CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high‐risk disease
Jeroen E. J. Guikema, S. Hovenga, E. Vellenga, J. Conradie +6 more
2003British Journal of Haematology94 citations Open access
Semantic Scholar
Progression of a solitary plasmacytoma to multiple myeloma. A population‐based registry of the northern Netherlands
E. D. de Waal, M. Leene, N. Veeger, Hanneke J. Vos +8 more
2016British Journal of Haematology71 citations Open access
Semantic Scholar
Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation
S. Hovenga, J. D. de Wolf, Jej Guikema, H. Klip +4 more
2000Bone Marrow Transplantation60 citations Open access
Semantic Scholar
Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome
K. Boslooper, R. Kibbelaar, H. Storm, N. Veeger +8 more
2014Leukemia and Lymphoma56 citations
Semantic Scholar
Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation
Jeroen E. J. Guikema, E. Vellenga, Jorden M. Veeneman, S. Hovenga +3 more
1999British Journal of Haematology54 citations
Semantic Scholar
Zirconium-89-trastuzumab positron emission tomography as a tool to solve a clinical dilemma in a patient with breast cancer.
S. Gaykema, A. Brouwers, S. Hovenga, M. Lub-de Hooge +2 more
2012Journal of Clinical Oncology42 citations Open access
Semantic Scholar
Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance
K. V. van Spaendonck-Zwarts, S. Badeloe, S. Oosting, S. Hovenga +5 more
2011Familial Cancer40 citations Open access
Semantic Scholar
Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature
S. Hovenga, J. D. de Wolf, H. Klip, E. Vellenga
1997Bone Marrow Transplantation39 citations Open access
Semantic Scholar
Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study
S. Hovenga, S. Daenen, J. D. de Wolf, G. V. Van Imhoff +3 more
2005Annals of Hematology32 citations
Semantic Scholar
Methaemoglobinaemia after inhalation of nitric oxide for treatment of hydrochlorothiazide-induced pulmonary oedema.
S. Hovenga, Marco EF Koenders, T. V. van der Werf, H. Moshage +1 more
1996The Lancet32 citations
Semantic Scholar
CD27‐triggering on primary plasma cell leukaemia cells has anti‐apoptotic effects involving mitogen activated protein kinases
Jeroen E. J. Guikema, E. Vellenga, W. Abdulahad, S. Hovenga +1 more
2004British Journal of Haematology28 citations
Semantic Scholar
Combination therapy with bortezomib, continuous low‐dose cyclophosphamide and dexamethasone followed by one year of maintenance treatment for relapsed multiple myeloma patients
E. D. de Waal, L. de Munck, M. Hoogendoorn, G. Woolthuis +4 more
2015British Journal of Haematology18 citations Open access
Semantic Scholar
No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic status.
K. Boslooper, M. Hoogendoorn, E. V. van Roon, R. Kibbelaar +8 more
2017Cancer Epidemiology14 citations Open access
Semantic Scholar
Dog-bite induced sepsis: a report of four cases
S. Hovenga, J. Tulleken, L. V. M. Möller, S. A. Jackson +2 more
1997Intensive Care Medicine14 citations
Semantic Scholar
Bcl-xl expression in multiple myeloma
S. Peeters, S. Hovenga, S. Rosati, E. Vellenga
2005Medical Oncology12 citations
Semantic Scholar
Enteropathy-associated T-cell lymphoma presenting with eosinophilia.
S. Hovenga, H. de Graaf, P. Joosten, G. A. van den Berg +4 more
2003Netherlands Journal of Medicine11 citations
Semantic Scholar
Heterogeneity in the Multiple Myeloma Tumor Clone
J. Guikema, S. Hovenga, E. Vellenga, N. Bos
2004Leukemia and Lymphoma10 citations
Semantic Scholar
The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study
B. Oortgiesen, E. V. van Roon, P. Joosten, R. Kibbelaar +7 more
2017European Journal of Clinical Pharmacology7 citations Open access
Semantic Scholar
70-Gene signature-guided adjuvant systemic treatment adjustments in early-stage ER+ breast cancer patients: 7-year follow-up of a prospective multicenter cohort study
E. Verreck, A. Kuijer, J. V. van Steenhoven, J. Volders +18 more
2024Breast Cancer Research and Treatment1 citations Open access
Semantic Scholar
Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study
B. Oortgiesen, E. V. van Roon, P. Joosten, R. Kibbelaar +6 more
20141 citations
Semantic Scholar
Combined Treatment of Bortezomib, Continuous Low-Dose Cyclophosphamide and Dexamethasone Followed By One Year of Maintenance Treatment for Refractory or Relapsed Multiple Myeloma Patients: A Prospective Phase II Study
E. De, Linda Munck de, G. Woolthuis, Annet Velden Van Der +4 more
20141 citations
Semantic Scholar
CD27 is heterogeneously expressed on myeloma plasma cells and inhibits dexamethasone induced apoptosis.
J. Guikema, S. Hovenga, J. Smit, E. Vellenga +1 more
20011 citations
Semantic Scholar
University of Groningen Clinical and biological aspects of Multiple Myeloma
S. Hovenga
20170 citations
Semantic Scholar
A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy
K. Boslooper, P. Joosten, N. Veeger, R. Kibbelaar +5 more
20120 citations
Semantic Scholar
Clinical and biological aspects of Multiple Myeloma
S. Hovenga
20070 citations
Semantic Scholar
Clinical and biological aspects of multiple myeloma
J. Guikema, S. Hovenga, E. Vellenga, J. Conradie +8 more
20070 citations
Semantic Scholar
Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma. A prospective phase III study.
S. Hovenga, S. Daenen, J. D. De Wolf, G. V. Van Imhoff +2 more
20030 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Vellenga×13
Invite
E. Vellenga — researcher profile on SciRah
M. Hoogendoorn×8
Invite
M. Hoogendoorn — researcher profile on SciRah
N. Veeger×6
Invite
N. Veeger — researcher profile on SciRah
G. Woolthuis×6
Invite
G. Woolthuis — researcher profile on SciRah

×5

Invite

N. Bos — researcher profile on SciRah

R. Kibbelaar×5

Invite

R. Kibbelaar — researcher profile on SciRah

Invite

H. Storm — researcher profile on SciRah

E. V. van Roon×5

Invite

E. V. van Roon — researcher profile on SciRah

H. Kluin-Nelemans×5

Invite

H. Kluin-Nelemans — researcher profile on SciRah

Invite

P. Joosten — researcher profile on SciRah

B. V. van Rees×4

Invite

B. V. van Rees — researcher profile on SciRah

Jeroen E. J. Guikema×3

Invite

Jeroen E. J. Guikema — researcher profile on SciRah